Therapeutic effect of antimicrobial drugs against experimental infections due to Yersinia pestis in mice

Journal of Infection and Chemotherapy

Volumn 4, Issue 1, 1998, Pages 16-19

  Goto, Sachiko ^a   Tsuji, Akiyoshi ^a   Murai, Teiko ^a   Nishida, Minoru ^a   Tsukano, Hiroko ^b   Watanabe, Haruo ^b  

^a TOHO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Antimicrobials; Experimental infection model; In vivo effect; Yersinia pestis

Indexed keywords

EID: 27144548073     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02490060     Document Type: Article

References (8)

1. Kumar S. Plague in India. Lancet 1994;344:941-942.
2. WHO Weekly Epidemic Record. Human plague in 1994. World Health Organization 1996;71(No. 22):165-168.
3. Centers for Disease Control and Prevention. Prevention of plague: recommendations of the advisory committee on immunization practices. MMWR 1996;45(RR-14):1-15.
4. Bonacorsi SP, Scavizzi MR, Gutyoule A, Amouroux JH, Carniel E. Assessment of a fluoroquinolone, two β-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection. Antimicrob Agents Chemother 1994;38:481-486.
5. Smith MD, Vinh DX, Hoa NTT, Wain J, White NJ. In vitro antimicrobial susceptibilities of strains of Yersinia pestis. Antimicrob Agents Chemother 1995;39:2153-2154.
6. Goto S, Tsuji A, Murai T, Nishida M, Tsukano H, Watanabe H. In vitro activity of twenty-three antimicrobials against Yersinia pestis strains. J Infect Chemother 1995;1:133-134.
7. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 2nd ed. Approved Standard NCCLS Document M7-A2. Villanova: NCCLS, 1990.
8. Tsuji A, Kaneko Y, Yamaguchi K, Goto S. Correlation between the in vitro and in vivo effects of fourteen beta-lactam compounds in mice with systemic infection. Chemotherapy 1994;40:324-332.